{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T12:03:17Z","timestamp":1778846597322,"version":"3.51.4"},"reference-count":153,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,10,14]],"date-time":"2023-10-14T00:00:00Z","timestamp":1697241600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,10,14]],"date-time":"2023-10-14T00:00:00Z","timestamp":1697241600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Heart Fail Rev"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Diastolic heart failure (DHF), in which impaired ventricular filling leads to typical heart failure symptoms, represents over 50% of all heart failure cases and is linked with risk factors, including metabolic syndrome, hypertension, diabetes, and aging. A substantial proportion of patients with this disorder maintain normal left ventricular systolic function, as assessed by ejection fraction. Despite the high prevalence of DHF, no effective therapeutic agents are available to treat this condition, partially because the molecular mechanisms of diastolic dysfunction remain poorly understood. As such, by focusing on the underlying molecular and cellular processes contributing to DHF can yield new insights that can represent an exciting new avenue and propose a novel therapeutic approach for DHF treatment. This review discusses new developments from basic and clinical\/translational research to highlight current knowledge gaps, help define molecular determinants of diastolic dysfunction, and clarify new targets for treatment.<\/jats:p>","DOI":"10.1007\/s10741-023-10352-z","type":"journal-article","created":{"date-parts":[[2023,10,14]],"date-time":"2023-10-14T05:01:46Z","timestamp":1697259706000},"page":"79-93","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Myofilament dysfunction in diastolic heart failure"],"prefix":"10.1007","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6213-6673","authenticated-orcid":false,"given":"Anahita","family":"Aboonabi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark D.","family":"McCauley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,10,14]]},"reference":[{"issue":"2","key":"10352_CR1","doi-asserted-by":"publisher","first-page":"17","DOI":"10.7603\/s40782-014-0017-6","volume":"1","author":"Y Xu","year":"2014","unstructured":"Xu Y, Tian J, Huang X (2014) Troponin mutation caused diastolic dysfunction and experimental treatment in transgenic mice with cardiomyopathy. GSTF J Adv Med Res 1(2):17","journal-title":"GSTF J Adv Med Res"},{"issue":"18","key":"10352_CR2","first-page":"e895","volume":"145","author":"PA Heidenreich","year":"2022","unstructured":"Heidenreich PA et al (2022) 2022 AHA\/ACC\/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation 145(18):e895\u2013e1032","journal-title":"Circulation"},{"issue":"7","key":"10352_CR3","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/j.cardfail.2007.04.006","volume":"13","author":"K Chatterjee","year":"2007","unstructured":"Chatterjee K, Massie B (2007) Systolic and diastolic heart failure: differences and similarities. J Card Fail 13(7):569\u2013576","journal-title":"J Card Fail"},{"issue":"12","key":"10352_CR4","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1016\/j.cardfail.2020.07.010","volume":"26","author":"C Hage","year":"2020","unstructured":"Hage C et al (2020) Metabolomic profile in HFpEF vs HFrEF patients. J Cardiac Fail 26(12):1050\u20131059","journal-title":"J Cardiac Fail"},{"key":"10352_CR5","doi-asserted-by":"crossref","unstructured":"Wake R, Yoshikawa J, Yoshiyama M (2012) Diastolic heart failure. In: Echocardiography-in specific diseases. IntechOpen","DOI":"10.5772\/29705"},{"issue":"1","key":"10352_CR6","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.hfc.2007.10.007","volume":"4","author":"M Periasamy","year":"2008","unstructured":"Periasamy M, Janssen PM (2008) Molecular basis of diastolic dysfunction. Heart Fail Clin 4(1):13\u201321","journal-title":"Heart Fail Clin"},{"issue":"12","key":"10352_CR7","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1161\/01.RES.0000129254.25507.d6","volume":"94","author":"DA Kass","year":"2004","unstructured":"Kass DA, Bronzwaer JGF, Paulus WJ (2004) What mechanisms underlie diastolic dysfunction in heart failure? Circ Res 94(12):1533\u20131542","journal-title":"Circ Res"},{"key":"10352_CR8","unstructured":"Mostafa SS et al (2011) Correlation of heart-rate and cardiac cycle duration under different body positions and breathing. In: International Conference on Advances in Electrical Engineering (ICAEE)"},{"key":"10352_CR9","unstructured":"(2012) Diastolic dysfunction. In: Vincent J-L, Hall JB (eds) Encyclopedia of intensive care medicine. Berlin, Heidelberg, Springer Berlin Heidelberg, pp 718\u2013718"},{"issue":"5","key":"10352_CR10","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/j.pcad.2005.02.006","volume":"47","author":"MR Zile","year":"2005","unstructured":"Zile MR, Baicu CF, Bonnema DD (2005) Diastolic heart failure: definitions and terminology. Prog Cardiovasc Dis 47(5):307\u2013313","journal-title":"Prog Cardiovasc Dis"},{"issue":"22","key":"10352_CR11","doi-asserted-by":"publisher","first-page":"1795","DOI":"10.1161\/CIRCULATIONAHA.121.056589","volume":"144","author":"M Abdellatif","year":"2021","unstructured":"Abdellatif M, Sedej S, Kroemer G (2021) NAD+ metabolism in cardiac health, aging, and disease. Circulation 144(22):1795\u20131817","journal-title":"Circulation"},{"key":"10352_CR12","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.yjmcc.2013.07.010","volume":"63","author":"J Mori","year":"2013","unstructured":"Mori J et al (2013) Impact of the renin\u2013angiotensin system on cardiac energy metabolism in heart failure. J Mol Cell Cardiol 63:98\u2013106","journal-title":"J Mol Cell Cardiol"},{"issue":"11","key":"10352_CR13","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1161\/CIRCULATIONAHA.118.036259","volume":"139","author":"AA Kumar","year":"2019","unstructured":"Kumar AA, Kelly DP, Chirinos JA (2019) Mitochondrial dysfunction in heart failure with preserved ejection fraction. Circulation 139(11):1435\u20131450","journal-title":"Circulation"},{"issue":"12","key":"10352_CR14","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1161\/CIRCULATIONAHA.119.041886","volume":"141","author":"SJ Shah","year":"2020","unstructured":"Shah SJ et al (2020) Research priorities for heart failure with preserved ejection fraction: National Heart, Lung, and Blood Institute working group summary. Circulation 141(12):1001\u20131026","journal-title":"Circulation"},{"issue":"6","key":"10352_CR15","doi-asserted-by":"publisher","first-page":"1806","DOI":"10.1161\/01.CIR.87.6.1806","volume":"87","author":"WH Barry","year":"1993","unstructured":"Barry WH, Bridge JH (1993) Intracellular calcium homeostasis in cardiac myocytes. Circulation 87(6):1806\u20131815","journal-title":"Circulation"},{"issue":"1","key":"10352_CR16","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1146\/annurev.ph.41.030179.002353","volume":"41","author":"A Fabiato","year":"1979","unstructured":"Fabiato A, Fabiato F (1979) Calcium and cardiac excitation-contraction coupling. Annu Rev Physiol 41(1):473\u2013484","journal-title":"Annu Rev Physiol"},{"issue":"6868","key":"10352_CR17","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1038\/415198a","volume":"415","author":"DM Bers","year":"2002","unstructured":"Bers DM (2002) Cardiac excitation\u2013contraction coupling. Nature 415(6868):198\u2013205","journal-title":"Nature"},{"issue":"1","key":"10352_CR18","doi-asserted-by":"publisher","first-page":"C1","DOI":"10.1152\/ajpcell.1983.245.1.C1","volume":"245","author":"A Fabiato","year":"1983","unstructured":"Fabiato A (1983) Calcium-induced release of calcium from the cardiac sarcoplasmic reticulum. Am J Physiol Cell Physiol 245(1):C1\u2013C14","journal-title":"Am J Physiol Cell Physiol"},{"issue":"1","key":"10352_CR19","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0004133","volume":"4","author":"S Wang","year":"2009","unstructured":"Wang S et al (2009) Dilated cardiomyopathy with increased SR Ca2+ loading preceded by a hypercontractile state and diastolic failure in the \u03b11CTG mouse. PLoS ONE 4(1):e4133","journal-title":"PLoS ONE"},{"issue":"5134","key":"10352_CR20","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1126\/science.8235594","volume":"262","author":"H Cheng","year":"1993","unstructured":"Cheng H, Lederer WJ, Cannell MB (1993) Calcium sparks: elementary events underlying excitation-contraction coupling in heart muscle. Science 262(5134):740\u2013744","journal-title":"Science"},{"issue":"8","key":"10352_CR21","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1006\/jmcc.2002.2037","volume":"34","author":"G Hasenfuss","year":"2002","unstructured":"Hasenfuss G, Pieske B (2002) Calcium cycling in congestive heart failure. J Mol Cell Cardiol 34(8):951\u2013969","journal-title":"J Mol Cell Cardiol"},{"issue":"7","key":"10352_CR22","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1038\/nrm1151","volume":"4","author":"DH MacLennan","year":"2003","unstructured":"MacLennan DH, Kranias EG (2003) Phospholamban: a crucial regulator of cardiac contractility. Nat Rev Mol Cell Biol 4(7):566\u2013577","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"1","key":"10352_CR23","first-page":"I72","volume":"97","author":"KF Frank","year":"2002","unstructured":"Frank KF et al (2002) Modulation of SERCA: implications for the failing human heart. Basic Res Cardiol 97(1):I72\u2013I78","journal-title":"Basic Res Cardiol"},{"issue":"8","key":"10352_CR24","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1161\/hc0802.105564","volume":"105","author":"F del Monte","year":"2002","unstructured":"del Monte F et al (2002) Targeting phospholamban by gene transfer in human heart failure. Circulation 105(8):904\u2013907","journal-title":"Circulation"},{"issue":"4","key":"10352_CR25","doi-asserted-by":"publisher","first-page":"2556","DOI":"10.1074\/jbc.274.4.2556","volume":"274","author":"M Periasamy","year":"1999","unstructured":"Periasamy M et al (1999) Impaired cardiac performance in heterozygous mice with a null mutation in the sarco (endo) plasmic reticulum Ca2+-ATPase isoform 2 (SERCA2) gene. J Biol Chem 274(4):2556\u20132562","journal-title":"J Biol Chem"},{"issue":"2","key":"10352_CR26","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.yjmcc.2009.03.013","volume":"47","author":"KB Andersson","year":"2009","unstructured":"Andersson KB et al (2009) Moderate heart dysfunction in mice with inducible cardiomyocyte-specific excision of the Serca2 gene. J Mol Cell Cardiol 47(2):180\u2013187","journal-title":"J Mol Cell Cardiol"},{"issue":"25","key":"10352_CR27","doi-asserted-by":"publisher","first-page":"2669","DOI":"10.1161\/CIRCULATIONAHA.110.982298","volume":"122","author":"RJ van Oort","year":"2010","unstructured":"van Oort RJ et al (2010) Ryanodine receptor phosphorylation by CaMKII promotes life-threatening ventricular arrhythmias in mice with heart failure. Circulation 122(25):2669","journal-title":"Circulation"},{"issue":"3","key":"10352_CR28","first-page":"280","volume":"2013","author":"HA Al-Khayat","year":"2013","unstructured":"Al-Khayat HA (2013) Three-dimensional structure of the human myosin thick filament: clinical implications. Glob Cardiol Sci Pract 2013(3):280\u2013302","journal-title":"Glob Cardiol Sci Pract"},{"issue":"3","key":"10352_CR29","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.jsb.2004.12.003","volume":"149","author":"RW Kensler","year":"2005","unstructured":"Kensler RW (2005) The mammalian cardiac muscle thick filament: crossbridge arrangement. J Struct Biol 149(3):303\u2013312","journal-title":"J Struct Biol"},{"issue":"5117","key":"10352_CR30","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1126\/science.8316857","volume":"261","author":"I Rayment","year":"1993","unstructured":"Rayment I et al (1993) Three-dimensional structure of myosin subfragment-1: a molecular motor. Science 261(5117):50\u201358","journal-title":"Science"},{"issue":"4","key":"10352_CR31","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1016\/j.jmb.2008.10.013","volume":"384","author":"L Alamo","year":"2008","unstructured":"Alamo L et al (2008) Three-dimensional reconstruction of tarantula myosin filaments suggests how phosphorylation may regulate myosin activity. J Mol Biol 384(4):780\u2013797","journal-title":"J Mol Biol"},{"key":"10352_CR32","unstructured":"Saxton A, Tariq MA, Bordoni B (2021) Anatomy, thorax, cardiac muscle. In: StatPearls [Internet]. StatPearls Publishing"},{"key":"10352_CR33","unstructured":"Ripa R, George T, Sattar Y (2022) Physiology, cardiac muscle. In: StatPearls [Internet]. StatPearls Publishing"},{"issue":"1","key":"10352_CR34","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1006\/jmbi.1999.2865","volume":"290","author":"A Weiss","year":"1999","unstructured":"Weiss A, Schiaffino S, Leinwand LA (1999) Comparative sequence analysis of the complete human sarcomeric myosin heavy chain family: implications for functional diversity. J Mol Biol 290(1):61\u201375","journal-title":"J Mol Biol"},{"issue":"1","key":"10352_CR35","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1111\/j.1469-7793.1998.171by.x","volume":"513","author":"DP Fitzsimons","year":"1998","unstructured":"Fitzsimons DP, Patel JR, Moss RL (1998) Role of myosin heavy chain composition in kinetics of force development and relaxation in rat myocardium. J Physiol 513(1):171\u2013183","journal-title":"J Physiol"},{"issue":"11","key":"10352_CR36","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0001123","volume":"2","author":"N Volkmann","year":"2007","unstructured":"Volkmann N et al (2007) The R403Q myosin mutation implicated in familial hypertrophic cardiomyopathy causes disorder at the actomyosin interface. PLoS ONE 2(11):e1123","journal-title":"PLoS ONE"},{"issue":"8","key":"10352_CR37","doi-asserted-by":"publisher","first-page":"1775","DOI":"10.1172\/JCI1940","volume":"101","author":"M Spindler","year":"1998","unstructured":"Spindler M et al (1998) Diastolic dysfunction and altered energetics in the alphaMHC403\/+ mouse model of familial hypertrophic cardiomyopathy. J Clin Investig 101(8):1775\u20131783","journal-title":"J Clin Investig"},{"issue":"9","key":"10352_CR38","doi-asserted-by":"publisher","first-page":"3265","DOI":"10.1073\/pnas.85.9.3265","volume":"85","author":"B Brenner","year":"1988","unstructured":"Brenner B (1988) Effect of Ca2+ on cross-bridge turnover kinetics in skinned single rabbit psoas fibers: implications for regulation of muscle contraction. Proc Natl Acad Sci 85(9):3265\u20133269","journal-title":"Proc Natl Acad Sci"},{"key":"10352_CR39","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.yjmcc.2013.01.001","volume":"57","author":"T Kraft","year":"2013","unstructured":"Kraft T et al (2013) Familial hypertrophic cardiomyopathy: functional effects of myosin mutation R723G in cardiomyocytes. J Mol Cell Cardiol 57:13\u201322","journal-title":"J Mol Cell Cardiol"},{"issue":"12","key":"10352_CR40","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1161\/01.CIR.102.12.1346","volume":"102","author":"SF Nagueh","year":"2000","unstructured":"Nagueh SF et al (2000) Tissue Doppler imaging consistently detects myocardial contraction and relaxation abnormalities, irrespective of cardiac hypertrophy, in a transgenic rabbit model of human hypertrophic cardiomyopathy. Circulation 102(12):1346\u20131350","journal-title":"Circulation"},{"key":"10352_CR41","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/j.yjmcc.2014.06.011","volume":"74","author":"W Huang","year":"2014","unstructured":"Huang W et al (2014) Hypertrophic cardiomyopathy associated Lys104Glu mutation in the myosin regulatory light chain causes diastolic disturbance in mice. J Mol Cell Cardiol 74:318\u2013329","journal-title":"J Mol Cell Cardiol"},{"issue":"18","key":"10352_CR42","doi-asserted-by":"publisher","first-page":"3989","DOI":"10.1111\/febs.15243","volume":"287","author":"YH Sitbon","year":"2020","unstructured":"Sitbon YH et al (2020) Ablation of the N terminus of cardiac essential light chain promotes the super-relaxed state of myosin and counteracts hypercontractility in hypertrophic cardiomyopathy mutant mice. FEBS J 287(18):3989\u20134004","journal-title":"FEBS J"},{"issue":"31","key":"10352_CR43","doi-asserted-by":"publisher","first-page":"27582","DOI":"10.1074\/jbc.M111.252320","volume":"286","author":"W Song","year":"2011","unstructured":"Song W et al (2011) Molecular mechanism of the E99K mutation in cardiac actin (ACTC gene) that causes apical hypertrophy in man and mouse. J Biol Chem 286(31):27582\u201327593","journal-title":"J Biol Chem"},{"issue":"6944","key":"10352_CR44","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1038\/nature01780","volume":"424","author":"S Takeda","year":"2003","unstructured":"Takeda S et al (2003) Structure of the core domain of human cardiac troponin in the Ca2+-saturated form. Nature 424(6944):35\u201341","journal-title":"Nature"},{"issue":"10","key":"10352_CR45","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1136\/jcp.2003.015420","volume":"57","author":"S Sharma","year":"2004","unstructured":"Sharma S, Jackson PG, Makan J (2004) Cardiac troponins. J Clin Pathol 57(10):1025\u20131026","journal-title":"J Clin Pathol"},{"issue":"5","key":"10352_CR46","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1161\/01.RES.83.5.471","volume":"83","author":"RJ Solaro","year":"1998","unstructured":"Solaro RJ, Rarick HM (1998) Troponin and tropomyosin: proteins that switch on and tune in the activity of cardiac myofilaments. Circ Res 83(5):471\u2013480","journal-title":"Circ Res"},{"issue":"7","key":"10352_CR47","doi-asserted-by":"publisher","first-page":"5230","DOI":"10.1016\/S0021-9258(17)37679-2","volume":"269","author":"CS Farah","year":"1994","unstructured":"Farah CS et al (1994) Structural and regulatory functions of the NH2- and COOH-terminal regions of skeletal muscle troponin I. J Biol Chem 269(7):5230\u20135240","journal-title":"J Biol Chem"},{"issue":"3","key":"10352_CR48","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1111\/j.1432-1033.1997.00611.x","volume":"246","author":"S Takeda","year":"1997","unstructured":"Takeda S et al (1997) Structural and functional domains of the troponin complex revealed by limited digestion. Eur J Biochem 246(3):611\u2013617","journal-title":"Eur J Biochem"},{"key":"10352_CR49","doi-asserted-by":"publisher","first-page":"629","DOI":"10.3389\/fphys.2016.00629","volume":"7","author":"X Liu","year":"2016","unstructured":"Liu X et al (2016) Restrictive cardiomyopathy caused by troponin mutations: application of disease animal models in translational studies. Front Physiol 7:629","journal-title":"Front Physiol"},{"issue":"3","key":"10352_CR50","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1111\/j.1469-7793.2001.00863.x","volume":"536","author":"BM Wolska","year":"2001","unstructured":"Wolska BM et al (2001) Expression of slow skeletal troponin I in adult transgenic mouse heart muscle reduces the force decline observed during acidic conditions. J Physiol 536(3):863\u2013870","journal-title":"J Physiol"},{"issue":"4","key":"10352_CR51","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1161\/01.RES.0000117307.57798.F5","volume":"94","author":"E Takimoto","year":"2004","unstructured":"Takimoto E et al (2004) Frequency- and afterload-dependent cardiac modulation in vivo by troponin I with constitutively active protein kinase A phosphorylation sites. Circ Res 94(4):496\u2013504","journal-title":"Circ Res"},{"issue":"1","key":"10352_CR52","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1161\/01.RES.84.1.1","volume":"84","author":"X Huang","year":"1999","unstructured":"Huang X et al (1999) Cardiac troponin I gene knockout: a mouse model of myocardial troponin I deficiency. Circ Res 84(1):1\u20138","journal-title":"Circ Res"},{"key":"10352_CR53","first-page":"1569","volume":"25","author":"X-P Huang","year":"2004","unstructured":"Huang X-P, Du J-F (2004) Troponin I, cardiac diastolic dysfunction and restrictive cardiomyopathy. Acta Pharmacol Sin 25:1569\u20131575","journal-title":"Acta Pharmacol Sin"},{"key":"10352_CR54","unstructured":"Frey N et al (1998) Transgenic rats overexpressing a human cardiac troponin T deletion exhibit diastolic dysfunction in the \"working heart model\". In: Circulation. Lippincott Williams & Wilkins 227 East Washington Sq, Philadelphia, PA 19106 USA"},{"issue":"16","key":"10352_CR55","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1056\/NEJM199504203321603","volume":"332","author":"H Watkins","year":"1995","unstructured":"Watkins H et al (1995) Mutations in the genes for cardiac troponin T and \u03b1-tropomyosin in hypertrophic cardiomyopathy. N Engl J Med 332(16):1058\u20131065","journal-title":"N Engl J Med"},{"issue":"10","key":"10352_CR56","doi-asserted-by":"publisher","first-page":"1815","DOI":"10.1006\/jmcc.2001.1445","volume":"33","author":"R Prabhakar","year":"2001","unstructured":"Prabhakar R et al (2001) A familial hypertrophic cardiomyopathy \u03b1-tropomyosin mutation causes severe cardiac hypertrophy and death in mice. J Mol Cell Cardiol 33(10):1815\u20131828","journal-title":"J Mol Cell Cardiol"},{"issue":"6","key":"10352_CR57","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1080\/152165401753366087","volume":"51","author":"Y Gao","year":"2001","unstructured":"Gao Y et al (2001) Myosin light chain kinase as a multifunctional regulatory protein of smooth muscle contraction. IUBMB Life 51(6):337\u2013344","journal-title":"IUBMB Life"},{"issue":"5600","key":"10352_CR58","doi-asserted-by":"publisher","first-page":"1912","DOI":"10.1126\/science.1075762","volume":"298","author":"G Manning","year":"2002","unstructured":"Manning G et al (2002) The protein kinase complement of the human genome. Science 298(5600):1912\u20131934","journal-title":"Science"},{"issue":"27","key":"10352_CR59","doi-asserted-by":"publisher","first-page":"E3824","DOI":"10.1073\/pnas.1600633113","volume":"113","author":"AN Chang","year":"2016","unstructured":"Chang AN et al (2016) Cardiac myosin light chain is phosphorylated by Ca2+\/calmodulin-dependent and -independent kinase activities. Proc Natl Acad Sci 113(27):E3824\u2013E3833","journal-title":"Proc Natl Acad Sci"},{"issue":"4","key":"10352_CR60","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.tcm.2013.07.004","volume":"24","author":"F Sheikh","year":"2014","unstructured":"Sheikh F, Lyon RC, Chen J (2014) Getting the skinny on thick filament regulation in cardiac muscle biology and disease. Trends Cardiovasc Med 24(4):133\u2013141","journal-title":"Trends Cardiovasc Med"},{"issue":"2","key":"10352_CR61","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1093\/cvr\/cvq144","volume":"87","author":"Q Shen","year":"2010","unstructured":"Shen Q et al (2010) Myosin light chain kinase in microvascular endothelial barrier function. Cardiovasc Res 87(2):272\u2013280","journal-title":"Cardiovasc Res"},{"issue":"2","key":"10352_CR62","first-page":"313","volume":"258","author":"R Colbran","year":"1989","unstructured":"Colbran R et al (1989) Calcium\/calmodulin-dependent protein kinase II. Biochemical Journal 258(2):313","journal-title":"Biochemical Journal"},{"issue":"2","key":"10352_CR63","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a006023","volume":"7","author":"IY Kuo","year":"2015","unstructured":"Kuo IY, Ehrlich BE (2015) Signaling in muscle contraction. Cold Spring Harb Perspect Biol 7(2):a006023","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"10352_CR64","doi-asserted-by":"publisher","first-page":"696","DOI":"10.3389\/fphys.2019.00696","volume":"10","author":"CL Tougas","year":"2019","unstructured":"Tougas CL et al (2019) Heterozygous Mylk3 knockout mice partially recapitulate human DCM with heterozygous MYLK3 mutations. Front Physiol 10:696","journal-title":"Front Physiol"},{"issue":"30","key":"10352_CR65","doi-asserted-by":"publisher","first-page":"E4138","DOI":"10.1073\/pnas.1505819112","volume":"112","author":"C-C Yuan","year":"2015","unstructured":"Yuan C-C et al (2015) Constitutive phosphorylation of cardiac myosin regulatory light chain prevents development of hypertrophic cardiomyopathy in mice. Proc Natl Acad Sci 112(30):E4138\u2013E4146","journal-title":"Proc Natl Acad Sci"},{"key":"10352_CR66","first-page":"1","volume-title":"xPharm: The Comprehensive Pharmacology Reference","author":"MC Schaub","year":"2007","unstructured":"Schaub MC (2007) Myosin light chain phosphatase. In: Enna SJ, Bylund DB (eds) xPharm: The Comprehensive Pharmacology Reference. Elsevier, New York, pp 1\u20133"},{"key":"10352_CR67","doi-asserted-by":"crossref","unstructured":"Barford D, Das AK, Egloff MP (1998)\u00a0The structure and mechanism of protein phosphatases: insights into catalysis and regulation. Annu Rev Biophys Biomol Struct 27","DOI":"10.1146\/annurev.biophys.27.1.133"},{"issue":"2","key":"10352_CR68","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1111\/j.1742-4658.2012.08509.x","volume":"280","author":"W Peti","year":"2013","unstructured":"Peti W, Nairn AC, Page R (2013) Structural basis for protein phosphatase 1 regulation and specificity. FEBS J 280(2):596\u2013611","journal-title":"FEBS J"},{"issue":"1","key":"10352_CR69","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1006\/geno.1998.5222","volume":"49","author":"M Fujioka","year":"1998","unstructured":"Fujioka M et al (1998) A new isoform of human myosin phosphatase targeting\/regulatory subunit (MYPT2): cDNA cloning, tissue expression, and chromosomal mapping. Genomics 49(1):59\u201368","journal-title":"Genomics"},{"issue":"24","key":"10352_CR70","doi-asserted-by":"publisher","first-page":"21209","DOI":"10.1074\/jbc.M102615200","volume":"276","author":"I Tan","year":"2001","unstructured":"Tan I et al (2001) Phosphorylation of a novel myosin binding subunit of protein phosphatase 1 reveals a conserved mechanism in the regulation of actin cytoskeleton. J Biol Chem 276(24):21209\u201321216","journal-title":"J Biol Chem"},{"issue":"3","key":"10352_CR71","doi-asserted-by":"publisher","first-page":"L440","DOI":"10.1152\/ajplung.00325.2007","volume":"295","author":"C Csortos","year":"2008","unstructured":"Csortos C et al (2008) TIMAP is a positive regulator of pulmonary endothelial barrier function. American Journal of Physiology-Lung Cellular and Molecular Physiology 295(3):L440\u2013L450","journal-title":"American Journal of Physiology-Lung Cellular and Molecular Physiology"},{"issue":"16","key":"10352_CR72","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1161\/CIRCULATIONAHA.121.054465","volume":"144","author":"YS Han","year":"2021","unstructured":"Han YS et al (2021) Rat model of heart failure with preserved ejection fraction: changes in contractile proteins regulating Ca2+ cycling and vascular reactivity. Circulation 144(16):1355\u20131358","journal-title":"Circulation"},{"issue":"20","key":"10352_CR73","doi-asserted-by":"publisher","first-page":"2539","DOI":"10.1093\/eurheartj\/ehm037","volume":"28","author":"WJ Paulus","year":"2007","unstructured":"Paulus WJ et al (2007) How to diagnose diastolic heart failure: a consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the Heart Failure and Echocardiography Associations of the European Society of Cardiology. Eur Heart J 28(20):2539\u20132550","journal-title":"Eur Heart J"},{"issue":"1","key":"10352_CR74","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1113\/jphysiol.1981.sp013582","volume":"311","author":"L Ford","year":"1981","unstructured":"Ford L, Huxley A, Simmons R (1981) The relation between stiffness and filament overlap in stimulated frog muscle fibres. J Physiol 311(1):219\u2013249","journal-title":"J Physiol"},{"issue":"5","key":"10352_CR75","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1007\/BF01739758","volume":"11","author":"M Bagni","year":"1990","unstructured":"Bagni M et al (1990) Tension and stiffness of frog muscle fibres at full filament overlap. J Muscle Res Cell Motil 11(5):371\u2013377","journal-title":"J Muscle Res Cell Motil"},{"issue":"2","key":"10352_CR76","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/0735-1097(89)90507-X","volume":"13","author":"MF Stoddard","year":"1989","unstructured":"Stoddard MF et al (1989) Left ventricular diastolic function: comparison of pulsed Doppler echocardiographic and hemodynamic indexes in subjects with and without coronary artery disease. J Am Coll Cardiol 13(2):327\u2013336","journal-title":"J Am Coll Cardiol"},{"key":"10352_CR77","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.abb.2018.11.011","volume":"661","author":"PM Janssen","year":"2019","unstructured":"Janssen PM (2019) Myocardial relaxation in human heart failure: why sarcomere kinetics should be center-stage. Arch Biochem Biophys 661:145\u2013148","journal-title":"Arch Biochem Biophys"},{"issue":"5","key":"10352_CR78","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1016\/j.yjmcc.2009.11.014","volume":"48","author":"D Barefield","year":"2010","unstructured":"Barefield D, Sadayappan S (2010) Phosphorylation and function of cardiac myosin binding protein-C in health and disease. J Mol Cell Cardiol 48(5):866\u2013875","journal-title":"J Mol Cell Cardiol"},{"issue":"8","key":"10352_CR79","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1161\/01.RES.0000096363.85588.9A","volume":"93","author":"FS Korte","year":"2003","unstructured":"Korte FS et al (2003) Loaded shortening, power output, and rate of force redevelopment are increased with knockout of cardiac myosin binding protein-C. Circ Res 93(8):752\u2013758","journal-title":"Circ Res"},{"issue":"1","key":"10352_CR80","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.1400205","volume":"1","author":"MJ Previs","year":"2015","unstructured":"Previs MJ et al (2015) Myosin-binding protein C corrects an intrinsic inhomogeneity in cardiac excitation-contraction coupling. Sci Adv 1(1):e1400205","journal-title":"Sci Adv"},{"issue":"14","key":"10352_CR81","doi-asserted-by":"publisher","first-page":"1986","DOI":"10.1093\/cvr\/cvz111","volume":"115","author":"DW Kuster","year":"2019","unstructured":"Kuster DW et al (2019) Altered C10 domain in cardiac myosin binding protein-C results in hypertrophic cardiomyopathy. Cardiovasc Res 115(14):1986\u20131997","journal-title":"Cardiovasc Res"},{"key":"10352_CR82","unstructured":"Barefield D (2014) Haploinsufficiency of cardiac myosin binding protein-C in the development of hypertrophic cardiomyopathy"},{"issue":"6","key":"10352_CR83","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1161\/CIRCRESAHA.110.231670","volume":"108","author":"SP Harris","year":"2011","unstructured":"Harris SP, Lyons RG, Bezold KL (2011) In the thick of it: HCM-causing mutations in myosin binding proteins of the thick filament. Circ Res 108(6):751\u2013764","journal-title":"Circ Res"},{"issue":"5","key":"10352_CR84","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1161\/01.RES.0000012222.70819.64","volume":"90","author":"SP Harris","year":"2002","unstructured":"Harris SP et al (2002) Hypertrophic cardiomyopathy in cardiac myosin binding protein-C knockout mice. Circ Res 90(5):594\u2013601","journal-title":"Circ Res"},{"key":"10352_CR85","doi-asserted-by":"crossref","unstructured":"Rosas PC et al (2019) Cardiac myosin binding protein-C phosphorylation mitigates age-related cardiac dysfunction: hope for better aging? JACC 4(7):817\u2013830","DOI":"10.1016\/j.jacbts.2019.06.003"},{"issue":"6","key":"10352_CR86","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1161\/CIRCRESAHA.116.308904","volume":"119","author":"M Bull","year":"2016","unstructured":"Bull M et al (2016) Alternative splicing of titin restores diastolic function in an HFpEF-like genetic murine model (Ttn \u0394IAjxn). Circ Res 119(6):764\u2013772","journal-title":"Circ Res"},{"issue":"2","key":"10352_CR87","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1006\/bbrc.2002.6448","volume":"291","author":"M Itoh-Satoh","year":"2002","unstructured":"Itoh-Satoh M et al (2002) Titin mutations as the molecular basis for dilated cardiomyopathy. Biochem Biophys Res Commun 291(2):385\u2013393","journal-title":"Biochem Biophys Res Commun"},{"key":"10352_CR88","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.yjmcc.2017.04.006","volume":"108","author":"RE Slater","year":"2017","unstructured":"Slater RE, Strom JG, Granzier H (2017) Effect of exercise on passive myocardial stiffness in mice with diastolic dysfunction. J Mol Cell Cardiol 108:24\u201333","journal-title":"J Mol Cell Cardiol"},{"issue":"12","key":"10352_CR89","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1161\/CIRCRESAHA.119.316311","volume":"129","author":"D Soetkamp","year":"2021","unstructured":"Soetkamp D et al (2021) Myofilament phosphorylation in stem cell treated diastolic heart failure. Circ Res 129(12):1125\u20131140","journal-title":"Circ Res"},{"issue":"3","key":"10352_CR90","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1161\/CIRCRESAHA.117.312166","volume":"123","author":"A-E Hopf","year":"2018","unstructured":"Hopf A-E et al (2018) Diabetes-induced cardiomyocyte passive stiffening is caused by impaired insulin-dependent titin modification and can be modulated by neuregulin-1. Circ Res 123(3):342\u2013355","journal-title":"Circ Res"},{"issue":"1","key":"10352_CR91","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.gene.2015.04.077","volume":"566","author":"E Vafiadaki","year":"2015","unstructured":"Vafiadaki E, Arvanitis DA, Sanoudou D (2015) Muscle LIM protein: master regulator of cardiac and skeletal muscle functions. Gene 566(1):1\u20137","journal-title":"Gene"},{"issue":"3","key":"10352_CR92","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1016\/j.bbrc.2019.02.115","volume":"511","author":"Y Chang","year":"2019","unstructured":"Chang Y et al (2019) Zebrafish cysteine and glycine-rich protein 3 is essential for mechanical stability in skeletal muscles. Biochem Biophys Res Commun 511(3):604\u2013611","journal-title":"Biochem Biophys Res Commun"},{"issue":"7","key":"10352_CR93","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1161\/CIRCRESAHA.111.245787","volume":"109","author":"R Kn\u00f6ll","year":"2011","unstructured":"Kn\u00f6ll R et al (2011) Telethonin deficiency is associated with maladaptation to biomechanical stress in the mammalian heart. Circ Res 109(7):758\u2013769","journal-title":"Circ Res"},{"issue":"11","key":"10352_CR94","doi-asserted-by":"publisher","first-page":"2192","DOI":"10.1016\/j.jacc.2004.08.058","volume":"44","author":"T Hayashi","year":"2004","unstructured":"Hayashi T et al (2004) Tcap gene mutations in hypertrophic cardiomyopathy and dilated cardiomyopathy. J Am Coll Cardiol 44(11):2192\u20132201","journal-title":"J Am Coll Cardiol"},{"key":"10352_CR95","doi-asserted-by":"crossref","unstructured":"Chen SN et al (2008) Pathogenesis of hypertrophic cardiomyopathy caused by the myozenin 2 mutations involves calcineurin-dependent and -independent mechanisms. Am Heart Assoc","DOI":"10.1161\/circ.118.suppl_18.S_323-c"},{"issue":"2","key":"10352_CR96","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1242\/dev.125.2.327","volume":"125","author":"W Xu","year":"1998","unstructured":"Xu W, Baribault H, Adamson ED (1998) Vinculin knockout results in heart and brain defects during embryonic development. Development 125(2):327\u2013337","journal-title":"Development"},{"issue":"8","key":"10352_CR97","doi-asserted-by":"publisher","first-page":"849","DOI":"10.2310\/JIM.0b013e3181c5e074","volume":"57","author":"A Zemljic-Harpf","year":"2009","unstructured":"Zemljic-Harpf A, Manso AM, Ross RS (2009) Vinculin and talin: focus on the myocardium. J Investig Med 57(8):849\u2013855","journal-title":"J Investig Med"},{"key":"10352_CR98","doi-asserted-by":"crossref","unstructured":"Tangney JR et al (2013) Novel role for vinculin in ventricular myocyte mechanics and dysfunction. Biophysical J 104(7):1623\u20131633","DOI":"10.1016\/j.bpj.2013.02.021"},{"issue":"8","key":"10352_CR99","doi-asserted-by":"publisher","first-page":"1596","DOI":"10.1016\/j.ajpath.2020.04.006","volume":"190","author":"NA Noll","year":"2020","unstructured":"Noll NA, Lal H, Merryman WD (2020) Mouse models of heart failure with preserved or reduced ejection fraction. Am J Pathol 190(8):1596\u20131608","journal-title":"Am J Pathol"},{"issue":"12","key":"10352_CR100","doi-asserted-by":"publisher","first-page":"1906","DOI":"10.1161\/CIRCRESAHA.122.320257","volume":"130","author":"J Roh","year":"2022","unstructured":"Roh J et al (2022) Heart failure with preserved ejection fraction: heterogeneous syndrome, diverse preclinical models. Circ Res 130(12):1906\u20131925","journal-title":"Circ Res"},{"issue":"8","key":"10352_CR101","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1016\/j.jacc.2010.10.024","volume":"57","author":"M Kasner","year":"2011","unstructured":"Kasner M et al (2011) Diastolic tissue Doppler indexes correlate with the degree of collagen expression and cross-linking in heart failure and normal ejection fraction. J Am Coll Cardiol 57(8):977\u2013985","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"10352_CR102","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.jacc.2015.10.063","volume":"67","author":"B L\u00f3pez","year":"2016","unstructured":"L\u00f3pez B et al (2016) Myocardial collagen cross-linking is associated with heart failure hospitalization in patients with hypertensive heart failure. J Am Coll Cardiol 67(3):251\u2013260","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"10352_CR103","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1136\/hrt.2005.062950","volume":"92","author":"AF Leite-Moreira","year":"2006","unstructured":"Leite-Moreira AF (2006) Current perspectives in diastolic dysfunction and diastolic heart failure. Heart 92(5):712\u2013718","journal-title":"Heart"},{"issue":"7","key":"10352_CR104","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1038\/ncpcardio1245","volume":"5","author":"M Ouzounian","year":"2008","unstructured":"Ouzounian M, Lee DS, Liu PP (2008) Diastolic heart failure: mechanisms and controversies. Nat Clin Pract Cardiovasc Med 5(7):375\u2013386","journal-title":"Nat Clin Pract Cardiovasc Med"},{"key":"10352_CR105","doi-asserted-by":"crossref","unstructured":"Gonz\u00e1lez A et al (2019) The complex dynamics of myocardial interstitial fibrosis in heart failure. Focus on collagen cross-linking.\u00a0Biochim Biophys Acta Mol Cell Res 1866(9):1421\u20131432","DOI":"10.1016\/j.bbamcr.2019.06.001"},{"issue":"4","key":"10352_CR106","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1038\/s44161-022-00043-7","volume":"1","author":"SL Bowers","year":"2022","unstructured":"Bowers SL, Meng Q, Molkentin JD (2022) Fibroblasts orchestrate cellular crosstalk in the heart through the ECM. Nature Cardiovascular Research 1(4):312\u2013321","journal-title":"Nature Cardiovascular Research"},{"key":"10352_CR107","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1755-1536-5-15","volume":"5","author":"D Fan","year":"2012","unstructured":"Fan D et al (2012) Cardiac fibroblasts, fibrosis and extracellular matrix remodeling in heart disease. Fibrogenesis & tissue repair 5:1\u201313","journal-title":"Fibrogenesis & tissue repair"},{"key":"10352_CR108","doi-asserted-by":"crossref","unstructured":"Zile MR et al (201) Plasma biomarkers that reflect determinants of matrix composition identify the presence of left ventricular hypertrophy and diastolic heart failure. Circulation 4(3):246\u2013256","DOI":"10.1161\/CIRCHEARTFAILURE.110.958199"},{"issue":"14","key":"10352_CR109","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1161\/CIRCULATIONAHA.114.013215","volume":"131","author":"MR Zile","year":"2015","unstructured":"Zile MR et al (2015) Myocardial stiffness in patients with heart failure and a preserved ejection fraction: contributions of collagen and titin. Circulation 131(14):1247\u20131259","journal-title":"Circulation"},{"issue":"2","key":"10352_CR110","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1002\/ejhf.2422","volume":"24","author":"RB Patel","year":"2022","unstructured":"Patel RB, Shah SJ, Inciardi RM (2022) Collagen homeostasis of the left atrium: an emerging treatment target to prevent heart failure? Eur J Heart Fail 24(2):332","journal-title":"Eur J Heart Fail"},{"key":"10352_CR111","doi-asserted-by":"publisher","first-page":"345","DOI":"10.3389\/fphys.2020.00345","volume":"11","author":"D Kolijn","year":"2020","unstructured":"Kolijn D et al (2020) Enhanced cardiomyocyte function in hypertensive rats with diastolic dysfunction and human heart failure patients after acute treatment with soluble guanylyl cyclase (sGC) activator. Front Physiol 11:345","journal-title":"Front Physiol"},{"issue":"18","key":"10352_CR112","doi-asserted-by":"publisher","first-page":"1833","DOI":"10.1016\/j.jacc.2011.06.058","volume":"58","author":"A Gonz\u00e1lez","year":"2011","unstructured":"Gonz\u00e1lez A et al (2011) New targets to treat the structural remodeling of the myocardium. J Am Coll Cardiol 58(18):1833\u20131843","journal-title":"J Am Coll Cardiol"},{"issue":"7","key":"10352_CR113","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1161\/CIRCULATIONAHA.111.076075","volume":"126","author":"L van Heerebeek","year":"2012","unstructured":"van Heerebeek L et al (2012) Low myocardial protein kinase G activity in heart failure with preserved ejection fraction. Circulation 126(7):830\u2013839","journal-title":"Circulation"},{"key":"10352_CR114","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2020.613123","volume":"7","author":"W Zhao","year":"2020","unstructured":"Zhao W et al (2020) Effects of cardiomyocyte-specific deletion of STAT3\u2013a murine model of heart failure with preserved ejection fraction. Frontiers in Cardiovascular Medicine 7:613123","journal-title":"Frontiers in Cardiovascular Medicine"},{"issue":"2","key":"10352_CR115","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1093\/cvr\/cvaa123","volume":"117","author":"D Kolijn","year":"2021","unstructured":"Kolijn D et al (2021) Empagliflozin improves endothelial and cardiomyocyte function in human heart failure with preserved ejection fraction via reduced pro-inflammatory-oxidative pathways and protein kinase G\u03b1 oxidation. Cardiovasc Res 117(2):495\u2013507","journal-title":"Cardiovasc Res"},{"issue":"11","key":"10352_CR116","doi-asserted-by":"publisher","first-page":"2555","DOI":"10.3390\/molecules25112555","volume":"25","author":"I P\u00e9rez-Torres","year":"2020","unstructured":"P\u00e9rez-Torres I et al (2020) Nitrosative stress and its association with cardiometabolic disorders. Molecules 25(11):2555","journal-title":"Molecules"},{"key":"10352_CR117","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1007\/s12551-015-0175-5","volume":"7","author":"M Breitkreuz","year":"2015","unstructured":"Breitkreuz M, Hamdani N (2015) A change of heart: oxidative stress in governing muscle function? Biophys Rev 7:321\u2013341","journal-title":"Biophys Rev"},{"issue":"19","key":"10352_CR118","doi-asserted-by":"publisher","first-page":"7626","DOI":"10.1158\/0008-5472.CAN-09-0493","volume":"69","author":"DM Townsend","year":"2009","unstructured":"Townsend DM et al (2009) Nitrosative stress\u2013induced S-glutathionylation of protein disulfide isomerase leads to activation of the unfolded protein response. Can Res 69(19):7626\u20137634","journal-title":"Can Res"},{"issue":"7092","key":"10352_CR119","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1038\/nature04782","volume":"441","author":"T Uehara","year":"2006","unstructured":"Uehara T et al (2006) S-Nitrosylated protein-disulphide isomerase links protein misfolding to neurodegeneration. Nature 441(7092):513\u2013517","journal-title":"Nature"},{"key":"10352_CR120","doi-asserted-by":"crossref","unstructured":"Nasoni M et al (2023) When nitrosative stress hits the endoplasmic reticulum: possible implications in oxLDL\/oxysterols-induced endothelial dysfunction.\u00a0Free Radic Biol Med","DOI":"10.1016\/j.freeradbiomed.2023.08.008"},{"key":"10352_CR121","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/s12035-010-8113-9","volume":"41","author":"Z Gu","year":"2010","unstructured":"Gu Z, Nakamura T, Lipton SA (2010) Redox reactions induced by nitrosative stress mediate protein misfolding and mitochondrial dysfunction in neurodegenerative diseases. Mol Neurobiol 41:55\u201372","journal-title":"Mol Neurobiol"},{"issue":"1","key":"10352_CR122","doi-asserted-by":"publisher","first-page":"14812","DOI":"10.1038\/srep14812","volume":"5","author":"R Nakato","year":"2015","unstructured":"Nakato R et al (2015) Regulation of the unfolded protein response via S-nitrosylation of sensors of endoplasmic reticulum stress. Sci Rep 5(1):14812","journal-title":"Sci Rep"},{"key":"10352_CR123","doi-asserted-by":"crossref","unstructured":"Failure E, On DH (1998) How to diagnose diastolic heart failure. Eur Heart J\u00a019(7):990\u20131003","DOI":"10.1053\/euhj.1998.1057"},{"issue":"4","key":"10352_CR124","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/j.jacc.2009.12.003","volume":"55","author":"AM From","year":"2010","unstructured":"From AM, Scott CG, Chen HH (2010) The development of heart failure in patients with diabetes mellitus and pre-clinical diastolic dysfunction a population-based study. J Am Coll Cardiol 55(4):300\u2013305","journal-title":"J Am Coll Cardiol"},{"issue":"20","key":"10352_CR125","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1001\/jama.1996.03530440037034","volume":"275","author":"D Levy","year":"1996","unstructured":"Levy D et al (1996) The progression from hypertension to congestive heart failure. JAMA 275(20):1557\u20131562","journal-title":"JAMA"},{"issue":"8","key":"10352_CR126","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1136\/heartjnl-2018-314438","volume":"105","author":"AC Pinho-Gomes","year":"2019","unstructured":"Pinho-Gomes AC, Rahimi K (2019) Management of blood pressure in heart failure. Heart 105(8):589\u2013595","journal-title":"Heart"},{"issue":"4","key":"10352_CR127","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1161\/01.CIR.62.4.756","volume":"62","author":"Y Hirota","year":"1980","unstructured":"Hirota Y (1980) A clinical study of left ventricular relaxation. Circulation 62(4):756\u2013763","journal-title":"Circulation"},{"issue":"4","key":"10352_CR128","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/0033-0620(90)90017-V","volume":"32","author":"WC Little","year":"1990","unstructured":"Little WC, Downes TR (1990) Clinical evaluation of left ventricular diastolic performance. Prog Cardiovasc Dis 32(4):273\u2013290","journal-title":"Prog Cardiovasc Dis"},{"issue":"3","key":"10352_CR129","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1007\/s11886-009-0024-x","volume":"11","author":"S Husain","year":"2009","unstructured":"Husain S et al (2009) Invasive monitoring in patients with heart failure. Curr Cardiol Rep 11(3):159\u2013166","journal-title":"Curr Cardiol Rep"},{"key":"10352_CR130","doi-asserted-by":"publisher","first-page":"S13","DOI":"10.1016\/S1078-5884(11)60010-5","volume":"42","author":"P Cao","year":"2011","unstructured":"Cao P et al (2011) Chapter II: diagnostic methods. Eur J Vasc Endovasc Surg 42:S13\u2013S32","journal-title":"Eur J Vasc Endovasc Surg"},{"issue":"11","key":"10352_CR131","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.1093\/europace\/euw295","volume":"18","author":"P Kirchhof","year":"2016","unstructured":"Kirchhof P et al (2016) 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Europace 18(11):1609\u20131678","journal-title":"Europace"},{"issue":"3","key":"10352_CR132","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1016\/j.jacc.2005.09.032","volume":"47","author":"JK Oh","year":"2006","unstructured":"Oh JK et al (2006) Diastolic heart failure can be diagnosed by comprehensive two-dimensional and Doppler echocardiography. J Am Coll Cardiol 47(3):500\u2013506","journal-title":"J Am Coll Cardiol"},{"issue":"8","key":"10352_CR133","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.tcm.2006.05.003","volume":"16","author":"BA Borlaug","year":"2006","unstructured":"Borlaug BA, Kass DA (2006) Mechanisms of diastolic dysfunction in heart failure. Trends Cardiovasc Med 16(8):273\u2013279","journal-title":"Trends Cardiovasc Med"},{"key":"10352_CR134","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1146\/annurev.med.55.091902.104417","volume":"55","author":"WH Gaasch","year":"2004","unstructured":"Gaasch WH, Zile MR (2004) Left ventricular diastolic dysfunction and diastolic heart failure. Annu Rev Med 55:373\u2013394","journal-title":"Annu Rev Med"},{"key":"10352_CR135","doi-asserted-by":"crossref","unstructured":"Douglas PS (2003) The left atrium: a biomarker of chronicdiastolic dysfunction andcardiovascular disease risk. American College of Cardiology Foundation Washington, DC, (p. 1206\u20131207)","DOI":"10.1016\/S0735-1097(03)00956-2"},{"issue":"21","key":"10352_CR136","doi-asserted-by":"publisher","first-page":"2277","DOI":"10.1093\/eurheartj\/ehi406","volume":"26","author":"C Tsch\u00f6pe","year":"2005","unstructured":"Tsch\u00f6pe C et al (2005) The role of NT-proBNP in the diagnostics of isolated diastolic dysfunction: correlation with echocardiographic and invasive measurements. Eur Heart J 26(21):2277\u20132284","journal-title":"Eur Heart J"},{"issue":"7","key":"10352_CR137","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1093\/eurheartj\/ehi772","volume":"27","author":"S Watanabe","year":"2006","unstructured":"Watanabe S et al (2006) Myocardial stiffness is an important determinant of the plasma brain natriuretic peptide concentration in patients with both diastolic and systolic heart failure. Eur Heart J 27(7):832\u2013838","journal-title":"Eur Heart J"},{"issue":"2","key":"10352_CR138","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1067\/mhj.2002.123316","volume":"144","author":"BP Paelinck","year":"2002","unstructured":"Paelinck BP et al (2002) Assessment of diastolic function by cardiovascular magnetic resonance. Am Heart J 144(2):198\u2013205","journal-title":"Am Heart J"},{"issue":"4","key":"10352_CR139","doi-asserted-by":"publisher","first-page":"893","DOI":"10.3390\/tomography7040075","volume":"7","author":"EH Ibrahim","year":"2021","unstructured":"Ibrahim EH et al (2021) Diastolic cardiac function by MRI-imaging capabilities and clinical applications. Tomography 7(4):893\u2013914","journal-title":"Tomography"},{"key":"10352_CR140","doi-asserted-by":"crossref","unstructured":"Cremer PC et al (2022) Effect of mavacamten on diastolic function in patients with obstructive hypertrophic cardiomyopathy: insights from the VALOR-HCM study. Circulation 146(Suppl_1):A12577\u2013A12577","DOI":"10.1161\/circ.146.suppl_1.12577"},{"issue":"10253","key":"10352_CR141","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1016\/S0140-6736(20)31792-X","volume":"396","author":"I Olivotto","year":"2020","unstructured":"Olivotto I et al (2020) Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): a randomised, double-blind, placebo-controlled, phase 3 trial. The Lancet 396(10253):759\u2013769","journal-title":"The Lancet"},{"issue":"4","key":"10352_CR142","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1038\/clpt.2011.148","volume":"90","author":"P Raake","year":"2011","unstructured":"Raake P et al (2011) Gene therapy targets in heart failure: the path to translation. Clin Pharmacol Ther 90(4):542\u2013553","journal-title":"Clin Pharmacol Ther"},{"issue":"35","key":"10352_CR143","doi-asserted-by":"publisher","first-page":"E8143","DOI":"10.1073\/pnas.1809540115","volume":"115","author":"RL Anderson","year":"2018","unstructured":"Anderson RL et al (2018) Deciphering the super relaxed state of human \u03b2-cardiac myosin and the mode of action of mavacamten from myosin molecules to muscle fibers. Proc Natl Acad Sci 115(35):E8143\u2013E8152","journal-title":"Proc Natl Acad Sci"},{"issue":"5","key":"10352_CR144","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1124\/molpharm.121.000420","volume":"101","author":"M Halas","year":"2022","unstructured":"Halas M et al (2022) Effects of sarcomere activators and inhibitors targeting myosin cross-bridges on Ca2+-activation of mature and immature mouse cardiac myofilaments. Mol Pharmacol 101(5):286\u2013299","journal-title":"Mol Pharmacol"},{"issue":"16","key":"10352_CR145","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1056\/NEJMoa2107038","volume":"385","author":"SD Anker","year":"2021","unstructured":"Anker SD et al (2021) Empagliflozin in heart failure with a preserved ejection fraction. N Engl J Med 385(16):1451\u20131461","journal-title":"N Engl J Med"},{"issue":"17","key":"10352_CR146","doi-asserted-by":"publisher","first-page":"1673","DOI":"10.1161\/CIRCULATIONAHA.120.052503","volume":"143","author":"ME Nassif","year":"2021","unstructured":"Nassif ME et al (2021) Empagliflozin effects on pulmonary artery pressure in patients with heart failure: results from the EMBRACE-HF trial. Circulation 143(17):1673\u20131686","journal-title":"Circulation"},{"issue":"12","key":"10352_CR147","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1056\/NEJMoa2206286","volume":"387","author":"SD Solomon","year":"2022","unstructured":"Solomon SD et al (2022) Dapagliflozin in heart failure with mildly reduced or preserved ejection fraction. N Engl J Med 387(12):1089\u20131098","journal-title":"N Engl J Med"},{"issue":"14","key":"10352_CR148","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1056\/NEJMoa030207","volume":"348","author":"B Pitt","year":"2003","unstructured":"Pitt B et al (2003) Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med 348(14):1309\u20131321","journal-title":"N Engl J Med"},{"issue":"19","key":"10352_CR149","doi-asserted-by":"publisher","first-page":"2940","DOI":"10.1161\/CIRCULATIONAHA.105.571653","volume":"112","author":"H Izawa","year":"2005","unstructured":"Izawa H et al (2005) Mineralocorticoid receptor antagonism ameliorates left ventricular diastolic dysfunction and myocardial fibrosis in mildly symptomatic patients with idiopathic dilated cardiomyopathy: a pilot study. Circulation 112(19):2940\u20132945","journal-title":"Circulation"},{"issue":"15","key":"10352_CR150","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1056\/NEJMoa1313731","volume":"370","author":"B Pitt","year":"2014","unstructured":"Pitt B et al (2014) Spironolactone for heart failure with preserved ejection fraction. N Engl J Med 370(15):1383\u20131392","journal-title":"N Engl J Med"},{"issue":"15","key":"10352_CR151","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1056\/NEJMe1401231","volume":"370","author":"J McMurray","year":"2014","unstructured":"McMurray J, O\u2019Connor C (2014) Lessons from the TOPCAT trial. N Engl J Med 370(15):1453\u20131454","journal-title":"N Engl J Med"},{"key":"10352_CR152","doi-asserted-by":"crossref","unstructured":"Ryba DM et al (2019) Sphingosine-1-phosphate receptor modulator, FTY720, improves diastolic dysfunction and partially reverses atrial remodeling in a Tm-E180G mouse model linked to hypertrophic cardiomyopathy. Circulation\u00a012(11):e005835","DOI":"10.1161\/CIRCHEARTFAILURE.118.005835"},{"key":"10352_CR153","doi-asserted-by":"crossref","unstructured":"Rosas PC, Solaro RJ (2022) Implications of S-glutathionylation of sarcomere proteins in cardiac disorders, therapies, and diagnosis. Front Cardiovasc Med\u00a09","DOI":"10.3389\/fcvm.2022.1060716"}],"container-title":["Heart Failure Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10741-023-10352-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10741-023-10352-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10741-023-10352-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,29]],"date-time":"2024-02-29T18:24:26Z","timestamp":1709231066000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10741-023-10352-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,14]]},"references-count":153,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,1]]}},"alternative-id":["10352"],"URL":"https:\/\/doi.org\/10.1007\/s10741-023-10352-z","relation":{},"ISSN":["1573-7322"],"issn-type":[{"value":"1573-7322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,14]]},"assertion":[{"value":"18 September 2023","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 October 2023","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}